One study concluded that the drug “doesn’t act as a sport efficiency enhancing agent as raised by standard beliefs.”
It added, “Thus, hashish consumption previous to train must be averted in an effort to maximize efficiency in sports activities.”
A spokesman for WADA, Jon Fitzgerald, mentioned that WADA “consults with all stakeholders in relation to substances or strategies that maybe must be added or eliminated,” and he added that “all through this time, the U.S. has been constant in its strongly held place that WADA ought to hold hashish on the Record.”
Mr. Fitzgerald mentioned that the WADA authors “stand by” the 2011 scientific analysis, printed within the journal Sports activities Drugs, that appears expansively on the results of marijuana use on athletes. One part is dedicated to the drug’s potential to boost efficiency and attracts on a handful of earlier scientific research to assist that risk.
Consultants say the WADA evaluation goes past what the sooner papers really said.
In a single instance, the 2011 evaluation misstates the place expressed by a scientist named Jon Wagner in his 1989 paper titled “Abuse of Medication Used to Improve Athletic Efficiency.” The WADA paper asserts that Dr. Wagner “described hashish as ergogenic,” that means performance-enhancing. Dr. Wagner, a former assistant professor on the College of Nebraska who now works within the biotech trade, disagreed.
“I didn’t write that,” Dr. Wagner mentioned in an interview. Within the paper, he wrote that marijuana doesn’t enhance “important capability” or grip energy and that if marijuana helped in any respect, it will be by serving to an athlete calm down. In an interview, he mentioned he had taken that final concept from anecdotal conversations with tennis gamers.
“That’s simply it,” Dr. Wagner mentioned. “Individuals simply speaking.”
“That was like a throwaway line,” he added. “I didn’t think about it will have an effect on this planet of Olympics.”